Strontium ranelate treatment enhances hydroxyapatite-coated titanium screws fixation in osteoporotic rats.
Increased bone turnover with excessive bone resorption and decreased bone formation is known to impair implant fixation. Strontium ranelate is well known as an effective antiosteoporotic agent by its dual effect of antiresorbing and bone-forming activity. This study was designed to evaluate the effect of systemic strontium ranelate (SR) treatment on fixation of hydroxyapatite (HA)-coated titanium screws in ovariectomized (OVX) rats. Twelve weeks after being OVX (n=30) or sham (n=10) operated, 40 female Sprague-Dawley rats received unilateral implants in the proximal tibiae. The OVX rats were randomly divided into the following groups: OVX, OVX+SRL ("L" refers to low SR dose of 500 mg/kg/day), OVX+SRH ("H" refers to high SR dose of 1000 mg/kg/day).Twelve weeks after treatment, bone blocks with implants were evaluated with micro-CT and biomechanical push-out tests. Compared to OVX animals, SR treatment increased the bone volume ratio by 51.5% and 1.1-fold, the percentage osteointegration by 1.0-fold and 1.9-fold in micro-CT evaluation, and the maximal force by 1.9-fold and 3.3-fold in biomechanical push-out test, for the low and high dose of SR, respectively. Significant correlation between micro-CT and biomechanical properties demonstrated that trabecular parameters played an important role in predicting the biomechanical properties of implant fixation. Our findings suggest that SR treatment can dose-dependently improve HA-coated screw fixation in OVX rats and facilitate the stability of the implant in the osteoporotic bone.
Li
Yunfeng
Y
The State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, Sichuan University West China College of Stomatology, 14 Section 3 Ren Min Nan Lu, Chengdu, 610041, People's Republic of China.
Feng
Ge
G
Gao
Yuan
Y
Luo
En
E
Liu
Xiaoguang
X
Hu
Jing
J
D000818:Animals; D050071:Bone Density Conservation Agents / Q000494:pharmacology; D001862:Bone Resorption / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery; D001863:Bone Screws; D020099:Coated Materials, Biocompatible; D003131:Combined Modality Therapy; D017886:Durapatite; D005260:Female; D008422:Materials Testing; D009942:Organometallic Compounds / Q000494:pharmacology*; D016348:Osseointegration / Q000187:drug effects*; D010024:Osteoporosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery*; D010052:Ovariectomy; D019919:Prosthesis Implantation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013876:Thiophenes / Q000494:pharmacology*; D014025:Titanium; D055114:X-Ray Microtomography
D050071:Bone Density Conservation Agents; D020099:Coated Materials, Biocompatible; D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate; D017886:Durapatite; D014025:Titanium